Healy Chris, Viles-Gonzalez Juan F, Sacher Frederic, Coffey James O, d'Avila Andre
University of Miami Miller School of Medicine, Miami, FL, USA.
Curr Cardiol Rep. 2015 Aug;17(8):59. doi: 10.1007/s11886-015-0617-5.
The use of mechanical ventricular support devices in the management of patients with advanced heart failure continues to increase. These devices have been shown to prolong life as a destination therapy and to increase survival when used as a bridge to transplantation. However, they are associated with a high rate of complications, including bleeding, infection, device malfunction, and ventricular arrhythmias (VAs). The mechanical support provided by the device typically allows for VAs to be well tolerated in the acute setting, though there are numerous long-term complications related to VAs such as ventricular remodeling, right ventricular failure in patients with left ventricular assist devices, and possibly increased mortality. Controversy exists as to the appropriate role of implantable cardioverter defibrillators in these patients. This review will focus on the management options available for patients with mechanical ventricular support devices and VAs.
在晚期心力衰竭患者的治疗中,机械心室辅助装置的使用持续增加。这些装置已被证明作为终末期治疗可延长生命,作为移植过渡手段使用时可提高生存率。然而,它们与高并发症发生率相关,包括出血、感染、装置故障和室性心律失常(VA)。该装置提供的机械支持通常使VA在急性期能够得到较好耐受,尽管存在许多与VA相关的长期并发症,如心室重构、左心室辅助装置患者的右心室衰竭以及可能增加的死亡率。对于植入式心脏复律除颤器在这些患者中的适当作用存在争议。本综述将聚焦于机械心室辅助装置和VA患者可用的治疗选择。